ora logo
ora logo
  • Expertise
    Our Clinical Expertise
    With over 3,000 clinical ophthalmology projects completed, our teams are not just experts — they’re THE experts.
    Retina & Macular Diseases Glaucoma & Optic Neuropathies Cornea & Ocular Surface
    Cataract & Refractive Conditions Inflammatory & Autoimmune
  • Services
    Our Approach
    We have the right people, processes and technology to streamline research and development and deliver the highest quality results.
    Site Solutions Safety & Monitoring Data & Biostatistics Clinical Tools & Processes
    Regulatory Approach Ora Endpoints & Technologies PRE-IND & Scientific Advisory Meetings
  • Why Ora
    The Ora Way
    As the trusted guide of ophthalmic innovators, we’re here to help navigate the complexities of ophthalmic product development together.
    Our Global Reach The Blind Canvas Project Case Studies
    Driving Success in Global Study Start-up
    A Case Study in Myopia Progression Demonstrating Enrollment Success
    View all Case Studies
  • Company
    The Leadership Team
    Ophthalmic innovators have trusted our guidance for over 50 years. We’re leading the way in global ophthalmic product development through precision, expertise, and innovation.
    Employee Spotlight Careers Conference Schedule News & Press Releases
    FEATURED NEWS
    Ora appoints industry veteran Bill Sharbaugh as Chairman of the Board of Directors
    Read more
    EMPLOYEE SPOTLIGHT
    Shea Berkowitz profile pic
    Shea Berkowitz

    Associate Director, Clinical Operations
  • Resources
Contact Us
Contact Us

Area: Dry Eye and Ocular Surface

Ora EyeCup™

Ora and Macular Society Partner to Increase Patient Awareness and Participation in Clinical Research and Drive  Innovation in Eyecare Treatment

Ora, Inc. Partners with the North West London Clinical Trials Alliance to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments

Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons

Brim Biotechnology and Ora Announce Partnership to Accelerate Development of Regenerative Peptide Therapy, BRM421, for Dry Eye

Ora names Gustavo De Moreas MD, PHD their Chief Medical Officer

Anterior Segment Fact Sheet

← Previous

Ora Headquarters

  • 138 Haverhill Street
  • Suite 102
  • Andover, Massachusetts 01810
  • United States of America

Contact Us

  • Tel: +1 978 685 8900

Stay in Touch

Linkedin

Copyright © 2026 Ora LLC. All Rights Reserved.

Privacy Policy
Site Map
Contact Us